Redeye provides a short comment on the recently announced Q3 sales figure from Scandinavian ChemoTech. We are encouraged to see that sales continue to be strong even in the seasonally weaker summer months, and argue that this bodes well for continued strong performance throughout the remainder of the year. We maintain our estimates and fair value range on the back of the sales announcement.
LÄS MER
